Fractyl Health to Participate in Upcoming September Investor Conferences
September 03, 2024 07:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Participate in Upcoming September Investor Conferences
DXCM STOCK NOTICE: DexCom, Inc. is being Sued for Securities Fraud; Contact BFA Law Now about the Lawsuit if You Lost Money on Your Investment (Nasdaq:DXCM)
September 03, 2024 06:36 ET
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
September 03, 2024 06:30 ET
|
Embecta Corp.
embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system, a patch pump with a 300-unit insulin reservoir.
DXCM STOCK NEWS: A Securities Fraud Class Action has been Filed Against DexCom, Inc. -- Contact BFA Law before October Deadline if You Suffered Losses (Nasdaq:DXCM)
September 01, 2024 06:44 ET
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
Connected Diabetes Care Innovations and Growth Opportunity Analysis 2024: Funding, Emerging Digital Diabetes Care Technologies, and Partnerships Shaping the Future of Global Diabetes Care
August 15, 2024 06:28 ET
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Connected Diabetes Care: Innovations and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research provides...
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
August 08, 2024 08:00 ET
|
Fractyl Health, Inc.
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
July 30, 2024 07:00 ET
|
Fractyl Health, Inc.
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
[Latest] US Diabetes Devices Market Size/Share Worth USD 19.8 Billion by 2033 at a 7.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 23, 2024 13:30 ET
|
Custom Market Insights
Austin, TX, USA, July 23, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Diabetes Devices Market Size, Trends and Insights By Type (Blood Glucose...
Italian Home/Self Testing Coagulation Market Research 2024: Diabetes, Pregnancy, Ovulation, Occult Blood Sales Forecasts, Technology Trends, and Competitive Strategies
July 22, 2024 05:47 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "2024 Home/Self-Testing Market: Diabetes, Pregnancy, Ovulation, Occult Blood-- Sales Forecasts, Technology Trends, Competitive Strategies" report has...
Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada
July 16, 2024 08:30 ET
|
Biodexa Pharmaceuticals PLC
July 16, 2024 Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage...